| Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ... Nature biotechnology 34 (5), 547-555, 2016 | 1185 | 2016 |
| Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... Cancer discovery 7 (12), 1394-1403, 2017 | 900 | 2017 |
| Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis JA Talwalkar, DM Kurtz, SJ Schoenleber, CP West, VM Montori Clinical gastroenterology and hepatology 5 (10), 1214-1220, 2007 | 725 | 2007 |
| Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ... Nature communications 7 (1), 11815, 2016 | 650 | 2016 |
| Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 574 | 2020 |
| Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA F Scherer, DM Kurtz, AM Newman, H Stehr, AFM Craig, MS Esfahani, ... Science translational medicine 8 (364), 364ra155-364ra155, 2016 | 487 | 2016 |
| Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma DM Kurtz, F Scherer, MC Jin, J Soo, AFM Craig, MS Esfahani, JJ Chabon, ... Journal of Clinical Oncology 36 (28), 2845-2853, 2018 | 448 | 2018 |
| Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 365 | 2015 |
| Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis SJ Schoenleber, DM Kurtz, JA Talwalkar, LR Roberts, GJ Gores British journal of cancer 100 (9), 1385-1392, 2009 | 259 | 2009 |
| Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 251 | 2021 |
| Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials BA Swiglo, M Cosma, DN Flynn, DM Kurtz, ML LaBella, RJ Mullan, ... The Journal of Clinical Endocrinology & Metabolism 93 (4), 1153-1160, 2008 | 218 | 2008 |
| Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ... Gastroenterology 158 (3), 494-505. e6, 2020 | 213 | 2020 |
| Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction DM Kurtz, MS Esfahani, F Scherer, J Soo, MC Jin, CL Liu, AM Newman, ... Cell 178 (3), 699-713. e19, 2019 | 202 | 2019 |
| Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials M Cosma, BA Swiglo, DN Flynn, DM Kurtz, ML LaBella, RJ Mullan, ... The Journal of Clinical Endocrinology & Metabolism 93 (4), 1135-1142, 2008 | 198 | 2008 |
| The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma CB Steen, BA Luca, MS Esfahani, A Azizi, BJ Sworder, BY Nabet, ... Cancer cell 39 (10), 1422-1437. e10, 2021 | 192 | 2021 |
| A mathematical model of ctDNA shedding predicts tumor detection size S Avanzini, DM Kurtz, JJ Chabon, EJ Moding, SS Hori, SS Gambhir, ... Science advances 6 (50), eabc4308, 2020 | 177 | 2020 |
| Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course FM Cady, BP O'Neill, ME Law, PA Decker, DM Kurtz, C Giannini, ... Journal of clinical oncology 26 (29), 4814-4819, 2008 | 146 | 2008 |
| Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 133 | 2022 |
| KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ... Cancer discovery 10 (12), 1826-1841, 2020 | 129 | 2020 |
| Molecular profiling of single circulating tumor cells from lung cancer patients S Park, DJ Wong, CC Ooi, DM Kurtz, O Vermesh, A Aalipour, S Suh, ... Proceedings of the National Academy of Sciences 113 (52), E8379-E8386, 2016 | 115 | 2016 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of MedicineOverená e-mailová adresa na: stanford.edu
